LONDON, October 23, 2013 /PRNewswire/ --
Global healthcare company GSK reported Q3 results showing group sales growth +1%, earnings per share +16% and strong cash generation which has enabled the company to re-affirm its guidance for the full year.
In a video interview, CFO Simon Dingemans said the company was making good progress on reshaping and restructuring its cost base and that GSK was now seeing the benefit of savings in both in its operations and the transformed R&D business.
He also said that the emerging markets side to the business made a strong contribution to the whole, despite a sales decline in China which had been impacted by the investigation into its business there.
The interview and transcript are available now on http://video.merchantcantos.com.
MerchantCantos produces in-depth interviews, documentaries and webcasts with senior company executives. If you would like to contact us, please email email@example.com or phone +44(0)207-936-1352.
Copyright©2012 PR Newswire.
All rights reserved